Lincoln Pharmaceuticals Ltd

BSE: 531633

109

total announcements

LINCOLN.BO · 15 min delayed

Key Stats · Yahoo Finance · as of 09 Nov 2026

Market Cap

₹1,030 Cr

P/E (TTM)

10.6

EPS (TTM)

₹48.38

52W Low

₹439.95

52W High

₹770.00

Dividend Yield

0.35%

Beta

0.52

Price / Book

1.3

Return on Equity

12.69%

Debt / Equity

0.4

Revenue (TTM)

₹722 Cr

Gross Margin

50.74%

Operating Margin

10.35%

Announcements Discussion

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed BSE about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change17 Oct 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the cessation of Sr. General Manager.

BSECompany UpdateMgmt Change17 Oct 2026

Lincoln Pharmaceuticals Ltd

Change in Senior Management.

Lincoln Pharmaceuticals Ltd announced the resignation of Mr. Pradeep Kumar Yadav, Senior General Manager- Quality Assurance, due to personal reasons, effective October 17, 2026.

Read more →📎 1 attachment

BSEAGM/EGM16 Oct 2026

Lincoln Pharmaceuticals Ltd

with reference to the above, Please find enclosed herewith the Minutes of 32nd Annual General Meeting of the Company.

Lincoln Pharmaceuticals Ltd has submitted the minutes of its 32nd Annual General Meeting, which was held on September 30, 2026, through video conferencing. The meeting was attended by directors, statutory auditors, and other panelists. The minutes include discussions on various resolutions, auditor reports, and shareholder queries.

Read more →📎 1 attachment

BSECompany Update7 Oct 2026

Lincoln Pharmaceuticals Ltd

Certificate from RTA for the Quarter ended September 30, 2026 under Regulation 74(5) of SEBI (DP) Regulations, 2018.

Lincoln Pharmaceuticals Ltd has received a certificate from its Registrar & Share Transfer Agent (RTA) under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities for the quarter ended September 30, 2026.

Read more →📎 1 attachment

BSEAGM/EGMResults3 Oct 2026

Lincoln Pharmaceuticals Ltd

Submission of E-Voting Results of 32nd AGM along with the scrutinizer report as per Regulation 44 of SEBI (LODR) Regulation, 2015.

Lincoln Pharmaceuticals Ltd has submitted the e-voting results of its 32nd AGM, where resolutions to adopt audited financial statements, declare a dividend of Rs. 1.80 per equity share, and appoint a director were passed with requisite majority.

Read more →📎 1 attachment

BSEAGM/EGMResults30 Sept 2026

Lincoln Pharmaceuticals Ltd

Submission of Proceedings of the 32nd Annual General Meeting of the Company held today.

Lincoln Pharmaceuticals Ltd held its 32nd Annual General Meeting (AGM) on September 30, 2026, where the company's performance during the financial year ended March 31, 2026, was discussed. The meeting approved the audited financial statements, declared a dividend of Rs. 1.80 per equity share, and re-appointed two directors.

Read more →📎 1 attachment

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left" > </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the exchange about the cessation of Sr. General Manager - XBRL.

BSECompany UpdateMgmt Change24 Sept 2026

LINCOLN PHARMACEUTICALS LIMITED

LINCOLN PHARMACEUTICALS LIMITED has informed BSE about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent.<p><b>Details are as under:</b></p> <table width="100%" border="0" cellspacing="0" cellpadding="0"> <tbody> <tr> <td bgcolor="#d6d6d6"><table border="0" cellpadding="4" cellspacing="1" width="100%"> <tbody> <tr><td width="250" class="TTRow_left"> </td><td class="TTRow_left"><b> Details</b></td></tr> <tr><td ....

Lincoln Pharmaceuticals Limited has informed the BSE about the appointment of a Sr. General Manager.

← PreviousPage 2 of 6Next →